Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1477, 2005-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Atherosclerosis risk factors increase VTE risk with tamoxifen
Reactions Weekly, Vol. 1, Iss. 1041, 2005-01 ,pp. :
Access to resources
Recommend
Oral but not transdermal estrogens increase VTE risk
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Ximelagatran reduces risk of VTE
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis
Heart Drug, Vol. 1, Iss. 3, 2001-07 ,pp. :